Phosphorylation of the nervous system-specific growth cone protein GAP-43 by kinase C in vivo occurs exclusively in growth cones and distal axons, and the onset of this phosphorylation is delayed relative to the onset of axonogenesis, with the delay predicated on the time needed for axons to reach the vicinity of their targets (Meiri et al., 1991) . We have used a subcellular fraction of intact growth cones (IGCs) to investigate whether this induction of GAP-43 phosphorylation can be influenced by target-derived substances, and show here that increased phosphorylation of GAP-43 can be both stimulated and maintained by NGF at concentrations of 2 x lo-lo M. This low concentration of NGF and the subsequent phosphorylation of GAP-43 are both consistent with the interpretation that phosphorylation is due to the binding of NGF to a biologically active high-affinity receptor. Second, we used the monoclonal antibody 2G12 to show that the NGF-stimulated phosphorylation of GAP-43 occurs on serine4', the kinase C phosphorylation site, consistent with the results seen in vivo. Levels of phosphorylated GAP-43 in the intact IGCs are also modulated by calcium-stimulated dephosphorylation that could be inhibited by EGTA but not okadaic acid and that therefore resembled the calcineurinstimulated dephosphorylation reported in vitro. The results suggest that the spatial and temporal regulation of GAP-43 phosphorylation that occurs during axonogenesis in vivocan be regulated by target-derived neurotropic molecules, specifically NGF.
The establishment ofappropriate synaptic connections is crucial for the development of the nervous system, but the molecular basis for those functions of motility, adhesion to the substrate, and pathfinding that are responsible for target-directed axon outgrowth is poorly understood (reviewed by Bray and Hollenbeck, 1988) . For example, the growth cone that is transiently generated at the tips of developing or regenerating axons interacts with various soluble or substrate-associated neurotropic factors, but it is not known how these extracellular signals are transduced to generate an intracellular response (reviewed by Lander, 1987) . Because the growth cone responds to neurotropic factors by rather stereotyped, albeit dramatic, alterations in morphology, manifested as extension and retraction of lilopodia and lamellae that then orient the growing axon along appropriate pathways (see, e.g., Tosney and Landmesser, 1985a,b; Caudy and Bentley, 1986; Gundersen, 1987; Chitnis and Kuwada, 1990; Kuwada et al., 1990 ) one approach to understanding the molecular basis for the directionality of axon outgrowth is to determine how growth cone morphology is controlled by extracellular stimuli. By analogy with other motile cells, it is likely that the alterations to growth cone shape that occur following dynamic interactions with the substrate (Tomaselli et al., 1986; Pfenninger, 1987; Matsunaga et al., 1988) are mediated via the proteins of the membrane skeleton; this structure, located subjacent to the plasma membrane, links the membrane with the actin filamentous cytoskeleton and is responsible for maintaining cell shape (reviewed by Mangeat, 1988) .
The so-called "growth-associated" protein GAP-43 is a nervous system-specific phosphoprotein that is specifically enriched in the membrane skeleton of growth cones (Meiri et al., , 1988 Meiri and Gordon-Weeks, 1990 ). Interest in this protein arose following observations that its axonal transport is dramatically induced in neurons that are growing axons during development or regeneration but that this induction is not reinstated in the injured axons of neurons that do not normally regenerate, such as the mammalian CNS, suggesting that it may be intimately involved in axon outgrowth (Skene and Willard, 198 1) . While the enrichment of GAP-43 in the membrane skeleton, together with its localization at areas that are tightly attached to the substrate, also supports the notion that GAP-43 is involved in membrane cytoskeleton interactions in the growth cone Meit-i and Gordon-Weeks, 1990 ) it is not known what these interactions may be or how they may be regulated. It seems likely that posttranslational modifications of GAP-43 will be important in modifying its behavior; in fact, we have recently shown that phosphorylation of GAP-43 by kinase C in vivo occurs exclusively in growth cones and distal axons. Furthermore, the onset of this phosphorylation is delayed relative to the onset of axonogenesis, with the delay predicated on the time needed for axons to reach the vicinity oftheir targets (Meiri et al., 1991) . These data, together with demonstrations that GAP-43 phosphorylation by kinase C can arise as a consequence of stimulation of exocytosis (Dekker et al., 1989) , membrane depolarization (Dekker et al., 1990) and treatment with muscarinic agonists (Van Hoof et al., 1989) suggest a role for GAP-43 in the response of the growth cone membrane skeleton to the transduction of extracellular signals. * NGF-stimulated Phosphorylation of Because GAP-43 phosphorylation by kinase C in vivo is so precisely regulated in a manner that suggests an involvement of the proximity of growing axons to their targets, we have considered the possibility that it may be affected by target-derived neurotropic factors. In order to approach this question, we had to circumvent the two major drawbacks of using either primary neuronal cultures or cell lines to study phosphorylation events in growth cones, namely, the difficulties of differentiating between the biochemical reactions that occur in the growth cone and those that are ongoing elsewhere in the neuron, as well as the problems involved in correlating the events that are occurring in the regenerating neurites actually present in primary tissue culture, with those that occur during axonogenesis in vivo. We avoided these problems by using a subcellular fractionation procedure to isolate intact growth cones from the forebrains of fetal or neonatal rats (Gordon-Weeks and Lockerbie, 1984; Gordon-weeks, 1987) . Not only are the ultrastructures of the isolated growth cones (IGCs) prepared by this method well preserved (Gordon-Weeks and Lockerbie, 1984) but their ability to attach to a substrate in a manner that is dependent on actin polymerization (Gordon-Weeks and Lockerbie, 1984) as well as to take up neurotransmitters and release them upon depolarization (Lockerbie et al., 1985) furthermore suggests that aspects of their physiological integrity are also maintained. We show here the use of this model system to study signal transduction processes in growth cones: the intact IGCs are able to synthesize radiolabeled ATP from JZP-orthophosphate, enabling us to detect increased phosphate incorporation into specific growth cone proteins after their phosphorylation had been stimulated by specific kinases. Phosphorylation of GAP-43 in intact IGCs was stimulated by 2.5s NGF with a Kd of 2 x lo-lo M, consistent with the interpretation that phosphorylation occurred subsequent to the binding of NGF to a high-affinity receptor. This phosphorylation occurred on serine41, the residue phosphorylated by kinase C, enabling us to use our antibody that specifically recognizes phosphoserine41 on GAP-43, to show that steady state levels of phosphorylated GAP-43 in growth cones are increased and maintained during incubation with NGF. We have also demonstrated that ongoing dephosphorylation of GAP-43 in intact IGCs in a manner that is stimulated by the presence of extracellular calcium. The dephosphorylation of GAP-43 can be prevented by incubating IGCs with EGTA but is unaffected by okadaic acid. This result is consistent with the finding that dephosphorylation of GAP-43 by calcineurin occurs in vitro (Liu and Storm, 1989) . The results are discussed with reference to both the neurotrophic and neurotropic actions of NGF as well as the regulation of interactions between proteins of the growth cone membrane skeleton by extracellular signals.
Materials and Methods Preparation of isolated growth cones
Septal and hippocampal areas were dissected from postnatal day 14 (Pld; day of birth is Pl) rat forebrains and used in the preparation of isolated growth cones (IGCs) as has been described previously (Meiri and Gordon-Weeks, 1990 ) with the following modifications: material banding at the interface between the sample and the 7% Ficoll solution following the first density gradient step was diluted 1:5 by adding Krebs's solution dropwise while stirring over ice (except where otherwise stated, Krebs's solution contains 145 mM NaCl, 5 mM KCI, 1.3 mM MgCl,, 1.2 mM NaH,PO,, 10 mM glucose, 20 mM HEPES, pH 7.4). The resultant suspension was centrifuged at 14,500 x g,, for 50 min at 4°C and the pellet was resuspended in Krebs's solution at a concentration of about 3 mgml.
Phosphorylations
In vitro. Freshly prepared IGCs in Krebs's buffer at a concentration of about 3 mg/ml were pelleted in a microfuge at 4°C and then osmotically lysed in a solution containing (final concentrations) 25 mM Tris (pH 7.4) 10 mM MgCI,, 1 mM EGTA, and 1 mM dithiothreitol, by brief sonication. The suspension was centrifuged at 100,000 x g for 30 min at 4°C and the pellets were resuspended in the same solution at a final concentration of 1.5 mg/ml. After preincubation of 75 Kg aliquots for 90 set at room temperature, phosphorylation was initiated by the addition of 200 PM +*P-ATP (specific activity, 5 Ci/mmol). In some cases, phosphorylation was stimulated with NGF; precise details of reaction conditions appear in the appropriate Results section. Phosphorylation was stopped after 25 set by the addition of boiling I O/o SDS solution.
Intact ZGCs. Intact septal and hippocampal IGCs at a concentration of about 3 mg/ml were preincubated for 15 min at 37°C in Krebs's solution, and then 32P-orthophosphate was added to a final concentration of 1 mCi JZP/mg IGCs. After incubation for 30 min at 37°C with shaking, the suspensions were microfuged briefly to remove unincorporated phosphate. The pellets were then resuspended in Krebs's buffer at a concentration of 3 mg/ml, and aliquots containing 75 rg of protein were diluted 1: 1 with Krebs's buffer that contained specific stimulators of phosphorylation (see Results). In some cases where dephosphorylation was to be studied, the Krebs's solution also contained 1.2 mM CaCI, plus 1 PM A23 187, or 1 mM EGTA, or 1 PM okadaic acid. For maximal and reproducible stimulation of phosphorylation, it was crucial to aerate the samples every minute for 10 set by gently bubbling through air containing 5% CO,. This was particularly important for long-term (> 20 min) experiments. Stimulation of phosphorylation after specific times (see Results) was terminated by dropping the samples into liquid nitrogen.
IdentiJication of serine" as the NGF-stimulated phosphorylation site
Phosphorylation of GAP-43 was stimulated in intact IGCs with NGF, as described above, and GAP-43 was then purified from the IGCs by extraction with base followed by reverse-phase HPLC. Purified GAP-43 was digested to completion with trypsin, and the resultant peptides were separated by reverse-phase HPLC using a C, column, as previously described (Meiri et al., 199 1) . Phosphate incorporation into the tryptic peptides was detected by Cerenkov counting, and the peptides were then dot blotted onto Immobilon paper. Immunoreactivity of the peptides adsorbed onto the dot blot was detected with the monoclonal antibody 2G12 that reacts specifically with phosphoserine41 (Meiri et al., 199 1) and visualized using biotinylated secondary antibodies and a biotinavidin horseradish peroxidase system (Vectastain, Vector Labs., Burlingame, CA). Results were compared with control (unstimulated) IGCs and IGCs that had their phosphorylation stimulated in vitro with NGF.
General techniques
Electrophoresis and Western blotting. One-dimensional analysis of proteins (Laemmli, 1970) used either 10% or 3-14% gradient SDS gels. Two-dimensional isoelectric focusing (IEF) gels were run for 7000 V/hr in the first dimension to focus acidic proteins completely including GAP-43, and on 10% SDS-PAGE in the second dimension . 1991 : Meiri and Gordon-Weeks. 1990 ). Gels were stained with Coomassik blue, and scanning absorbance densitometry at 4 15 nm was performed on wet gels using a Shimadzu CS-9000 densitometer. Western blotting was carried out as described previously (Meiri and Gordon-Weeks, 1990 ). Proteins were transferred onto Immobilon paper, and immunoreactivity was visualized on Western blots as described above. To perform scanning reflectance densitometry (at 500 nm) of Western blots, the amount of GAP-43 loaded onto the gels was adjusted so that the signal obtained from the Western blot was not saturated and was within the linear range of the densitometer, by comparison with standard curves that were run in parallel. Protein concentrations were determined using a Coomassie-based assay (Bradford, 1976) with modifications (Read and Northcote, 1981; Gogstadt and Krutnes, 1982) to enable measurement of membrane proteins. Bovine serum albumin was used as standard.
Autoradiographyand scintillation counting. For autoradiography, gels were dried and exposed to Kodak X-Omat-K or X-Omat-AR film. For scintillation counting, pieces cut from dried gels were solubilized in hydrogen peroxide, and liquid scintillant was added prior to counting. Phosphorylation of proteins in intact IGCs: treatment with phorbol ester In order to investigate whether intact IGCs are able to synthesize ATP and then use it to phosphorylate IGC proteins, we prepared IGCs from Pl rat forebrains and incubated them with 32P-orthophosphate. Examination of autoradiographs of proteins that had been separated by SDS-PAGE showed that radiolabeled ATP, synthesized by the IGCs, had indeed been incorporated into protein. Maximal and reproducible incorporation occurred when (1) the Krebs's solution containing the 3*P-orthophosphate in which the IGCs were incubated did not contain either phosphate or calcium ions, (2) incubation of the IGC protein was for 30 min and used 1 mCi 32P-orthophosphate/mg IGC protein, and (3) the suspensions were aerated with air that contained 5% CO, for 10 set every minute (Fig. 1A) . We next incubated the intact, prelabeled IGCs for 5 min in the presence of 10 nM phorbol dibutyrate (PDBU), in order to activate protein kinase C. Phosphorylation of specific kinase C substrates were identified by comparing autoradiographs of radiolabeled proteins with controls (Fig. 1B) . GAP-43 was identified as one of the kinase C substrates in two ways: by comparison of the autoradiographs with previously published autoradiographs of 2-D gels that had been prepared and run in precisely the same way (Meiri et al., , 1988 and also by its immunoreactivity on 2-D Western blots with the monoclonal antibody 5E7 as has been described previously (Meiri et al., 199 1; results not shown).
The stimulation of GAP-43 phosphorylation by PDBU was determined by scintillation counting of the 32P-radiolabeled GAP-43 spots that were excised from the 2-D gels ( Fig. IB ; see also Fig. 2C') . The maximal stimulation of phosphorylation was fourto fivefold, similar to the levels that were detected in a series of experiments that used intact synaptosomes to study similar phosphorylation reactions (Yip and Kelly, 1989) . In control experiments, any phosphorylation occurring subsequent to the rapid freezing of the IGCs in liquid nitrogen was ruled out by adding T-~~P-ATP to the IGCs as they were frozen and then processing them for 2-D gels as described. These samples showed barely detectable phosphate incorporation into IGC proteins only after extended exposure of the x-ray film (Fig. 1 c) .
NGF-stimulated phosphorylation of GAP-43 in intact growth cones In vivo, kinase C phosphorylation of GAP-43 in distal axons and growth cones occurs after the onset of axonogenesis, at a time when growing axons are in the proximity of their targets, thereby suggesting that the onset of GAP-43 phosphorylation could be influenced by target-derived molecules (Meiri et al., 1991) . One likely candidate would be the neurotrophic and A, Doseresponse curve generated from the scintillation counts derived from GAP-43 spots cut out of 2-D gels following separation of IGC protein that had been incubated with NGF and 3ZP-orthophosphate. Each point represents the mean of four separate experiments *SD. Half-maximal stimulation ofGAPphosphorylation occurred with 2 x lo-r0 M 2.5s NGF. B, Dose-response curve generated from the scintillation counts derived from GAP-43 spots cut out of 2-D gels, following separation of IGC proteins that had been incubated in vitro with NGF and )*P-ATP. Each point represents the mean of four separate experiments + SD. Half-maximal phosphorylation of GAP-43 occurred with 1 x lo-r0 M 2.5s NGF. al., 1986; Rowland et al., 1987; Rowland-Gagne and Greene, 1990) . Therefore, if the onset of GAP-43 phosphorylation in vivo is regulated by NGF, it should occur subsequent to binding of NGF to its high-affinity receptor. Before describing the experiments in which we investigated stimulation of GAP-43 phosphorylation by NGF, it is important to reemphasize that consistently quantifiable results using the IGCs were only obtained when air that contained 5% CO, was bubbled through the suspension of IGCs once every minute for 10 sec. We presume that, in the absence of bicarbonate in the Krebs's solution, the CO, serves to maintain intracellular pH within a required range (reviewed by Frelin et al., 1988) . Intact septal/hippocampal IGCs were prepared and preincubated for 30 min with j*Porthophosphate, in Krebs's buffer as before. Maximal, twofold stimulation of GAP-43 phosphorylation could be detected after incubating the IGCs for 1 min with 4 x 10 I0 M 2.5s NGF (Fig. 3A,B) , thus demonstrating that GAP-43 phosphorylation in intact IGCs can be regulated by NGF. The degree of stimulation by NGF observed is at least partly due to the fact that even IGCs prepared from septaVhippocampa1 areas contain low numbers of NGF receptors. For example, in an experiment where double-labeling immunohistochemistry was used to quantitate the number of IGCs reactive with both GAP-43 and the antibody Al92 against the NGF receptor (a gift of Dr. E. M. Johnson, Washington University School of Medicine), only 22% -t 4% (N = 100 in each of 10 separate experiments) of all the IGCs were immunoreactive for both GAP-43 and A192. The low concentration of NGF that evoked the response suggested that a high-affinity NGF receptor might be involved. We therefore generated a dose-response curve to quantitate the kinetics of stimulation of phosphorylation, which showed that the concentration of NGF required to cause half-maximal stimulation of phosphorylation was 2 x lo-lo M.
To establish more accurately the concentration of NGF that would cause maximal incorporation of phosphate into GAP-43, the experiments were repeated with an in vitro preparation in which a high-specific-activity ATP could be used to phosphorylate the IGC proteins. IGCs were prepared from the septal/ hippocampal areas of Pl rat brains as described, gently lysed in hypotonic buffer, and then incubated with concentrations of 2.5s NGF ranging from lo-l2 M to 10e9 M for 25 set in the presence of 200 I.LM T-)~P-ATP (specific activity, 5 Ci/mmol) in Krebs's buffer. Proteins were separated on 2-D IEF gels and stained with Coomassie blue, as before. In order to quantitate NGF-stimulated incorporation of phosphate into GAP-43 accurately, scanning absorbance densitometry of the spot that corresponded to GAP-43 was performed on the wet, Coomassie blue-stained 2-D gels. The scintillation counts derived from the GAP-43 spots that were then cut out of the dried gels were subsequently adjusted to reflect the actual amount of GAP-43 protein present. To validate this approach and to allow comparisons between samples to be made, each second-dimension SDS gel contained the acid, GAP-43<ontaining, end from each of four first-dimension gels. Furthermore, duplicate samples were always run on different second-dimension gels to control for any variation in the intensity of Coomassie blue staining. In this way, we were able to account for the subtle differences in loading onto the first-dimension gels that may have affected the reproducibility of the results. These considerations were especially important in the experiments where phosphorylation was measured by incubating the intact IGCs with radiolabeled phosphate. We used the scintillation counts to generate a dosea ba The Journal of Neuroscience, October 1991, ff(10) 3159 b response curve, which enabled us to determine that the minimum concentration of 2.5s NGF that stimulated phosphate incorporation into GAP-43 was 2 x 10-l' M, whereas maximum stimulation of phosphorylation measured occurred at 2 x 1 O-9 M (Fig. 2) . This result is consistent with the interpretation that stimulation of GAP-43 phosphorylation in the septal and hippocampal IGCs occurred subsequent to the binding of NGF to its biologically active high-affinity receptor .
NGF-stimulated phosphorylation of GAP-43 occurs on serim?' One drawback to the use of incorporation of radiolabeled phosphate to measure stimulation of protein phosphorylation in intact systems is that it is not possible to determine whether the actual number of phosphorylated molecules has increased or whether the increased phosphate incorporation is merely a result of stimulation of the turnover of phosphate on the same number of phosphorylated molecules. This distinction is of particular importance here since the in vivo results had clearly shown an increased number of phosphorylated GAP-43 molecules in growth cones approaching their targets (Meiri et al., 1991) . In those experiments, we used a monoclonal antibody, 2G12, that specifically recognizes phosphoserine4', the amino acid phosphorylated by kinase C, to detect the increased numbers of GAP-43 molecules in the growth cones. Thus, if NGF is responsible for the increased phosphorylation of GAP-43 that we observed in vivo, increased phosphorylation of GAP-43 in response to NGF should be detectable with the 2G12 antibody in the IGCs, also. We therefore determined whether serine4i on GAP-43 is phosphorylated following NGF treatment as follows: IGCs were phosphorylated with 4 x 1O-9 M NGF. GAP-43 was purified from them by base extraction and reverse-phase HPLC (Fig.  4A,B) and then subjected to tryptic digestion, as we have described before (Meiri et al., 199 1) . Stimulation of GAP-43 phosphorylation by NGF generated a single phosphopeptide that was sequenced as IQAS(PO,)FR (indicating that radiolabeled phosphate was evolved on the fourth cycle). This sequence, which arises from GAP-43 residues 38-43 and includes serine41, the kinase C phosphorylation site, is the one that reacts with the monoclonal antibody 2G12K7, as we have shown previously (Meiri et al., 199 1) . Although this result gives us no direct information as to the kinase responsible for generating phosphoserine41, it is consistent with the results obtained in vivo and furthermore means that we were able to use the antibody to quantitate the NGF-induced changes in numbers of phosphorylated GAP-43 molecules in intact IGCs that could not have been determined solely by examining incorporation of radiolabeled phosphate.
NGF increases and maintains the steady state levels of GAP-43 phosphorylation in IGCs
In experiments where the antibody 2G12 was used to measure actual levels of phosphorylated GAP-43 in intact IGCs, septal and hippocampal IGCs were prepared as before but were not (Meiri and Gordon-Weeks, 1990 ) showed a twofold increase in 2G12 immunoreactivity, reflecting increased phosphorylation of serine"' (compare Fig. 5A,C; for quantitation, see also Fig. 6A ). This result demonstrates that NGF actually increased the net number of phosphorylated GAP-43 molecules in the IGCs rather than merely inducing turnover of radiolabeled phosphate on the same number of phosphorylated molecules. Moreover, the approximately twofold increase in phosphorylation detected by antibody immunoreactivity is similar to the increase in radiolabeled phosphate incorporated into GAP-43 on NGF treatment, thus confirming that in these experiments the radiolabeling technique did accurately reflect the phosphorylation state of GAP-43 in intact IGCs. In other experiments where the IGCs were incubated in the presence of NGF for up to 2 hr, the increase in steady state levels of phosphorylated GAP-43 was maintained throughout that time (Fig. SC) . Furthermore, when similar experiments were also repeated using phorbol ester rather than c presence of 4 x lo-j0 M 2.5s NGF. Note the increased phosphorylation of GAP-43 in the NGF-treated IGCs compared with controls, and also the calcium-dependent dephosphorylation of GAP-43 that occurred in each case. Seven micrograms of total IGC protein were loaded into each lane. The experiment was repeated five times with similar results. NGF, the increased phosphotylation of GAP-43 detected also resembled that seen in the radiolabeling experiments (compare Fig. 5AJ ; for quantitation, see also Fig. 6A ).
Calcium-stimulated dephosphorylation and proteolysis of GAP-43 in intact IGCs
In the experiments in which intact IGCs were incubated for up to 2 hr with either 4 x 10m9 M NGF or 10 nM phorbol ester, a loss of immunoreactivity with 2G12 was seen whenever 1.2 mM calcium and 1 WM A23 187 were also included in the incubation solution (Fig. 5&C) . Under these circumstances, the loss of immunoreactivity that occurred even if NGF or phorbol ester was present throughout the incubation period became evident after about 5 min and had a half-time of about 20 min. Loss of immunoreactivity was also detected in the absence of added calcium and A23 187 if stimulators of phosphorylation were removed from the incubation solution after the initial 1 min incubation (Fig. 6C) . To determine whether this loss of immunoreactivity was caused by dephosphorylation or proteolysis of GAP-43, 1-D gels and Western blots were generated from parallel samples taken at the end of the incubation period (60 min), a time when loss of immunoreactivity would be expected to be maximal. For direct comparison, one of the samples was reacted with the antibody 5E7, which recognizes both phosphorylated and unphosphorylated GAP-43, while the other was reacted with 2G12. There was loss of immunoreactivity from both samples, but it was much more significant in the sample reacted with 2G12, reflecting dephosphorylation (Fig. 7) . In contrast, the loss of immunoreactivity detected by 5E7, presumably due to proteolysis, was variable but never exceeded 20% of the total loss of immunoreactivity. Thus, both dephosphorylation and proteolysis of GAP-43 in intact IGCs occur; both may represent important regulatory mechanisms and may be differentially stimulated. Loss of 2G12 immunoreactivity could be prevented by including 1 mM EGTA in the Krebs's solution but was not inhibited by concomitant incubation of the IGCs with 1 PM okadaic acid, a phosphatase -1 or -2A inhibitor that is active in intact systems (see Haystead et al., 1989) . While these experiments make no attempt to identify the relevant phosphatase, the results are consistent with the calcineurin-dependent dephosphorylation of GAP-43 previously observed to occur in vitro (Liu and Storm, 1989) . We did not investigate the calcium-stimulated proteolysis. and reacted with the antibody 5E7 that reacts with both phosphorylated and unphosphorylated forms (B). All of the samples were derived from the same fraction of IGCs that was incubated with NGF together with CaCl, and A23187 for either 1 min (left side of both) or 60 min (right side of both). Note that after 60 min 2Gl2 immunoreactivity, that is, phosphorylated GAP-43, is nearly absent (right side of A), whereas the equivalent aliquot reacted with SE7 shows a much smaller decrease in the total amount of GAP-43 present (right side of B). Seven micrograms were loaded into each lane. In the center lane, the prestained molecular weight standard fumarase (47 kDa) is bisected since both panels were originally derived from the same Western blot.
Discussion
We have combined two novel approaches in order to study the regulation of GAP-43 phosphorylation in growth cones. First, we have demonstrated ATP synthesis in a subcellular fraction of intact IGCs. Direct activation of protein kinase C with phorbol ester stimulated the phosphorylation of known kinase C substrates including GAP-43 in these IGCs, thus demonstrating the use of the preparation for studying phosphorylation reactions in the intact growth cone, since it circumvents the problem of biochemically distinguishing events occurring at the growth cone from those ongoing elsewhere in the neuron. Second, as an adjunct to this approach we have used our monoclonal antibody 2G12, which specifically detects the GAP-43 residue phosphoserine4', to show that NGF-dependent phosphorylation of GAP-43 in these intact IGCs occurs on serine4', the kinase C phosphorylation site. Furthermore, we demonstrated that incubation of intact IGCs with NGF causes a net increase in steady state levels of phosphorylated GAP-43 and that GAP-43 is also subject to calcium-stimulated dephosphorylation that is inhibited by EGTA but not okadaic acid.
Our results support the interpretation that NGF-stimulated phosphorylation of GAP-43 occurs subsequent to binding of NGF to a high-affinity receptor for the following reasons. First, significant stimulation of GAP-43 phosphorylation by NGF was detected only in IGCs prepared from septal and hippocampal areas of P 1 rat forebrains and not in those from whole forebrain, in agreement with immunohistochemical and in situ hybridization studies that show high levels of NGF receptor in septal and hippocampal areas at this stage during neuronal development (Buck et al., 1988; Emfors et al., 1988; Maisonpierre et al., 1990a,b) . In contrast, no differences in the degree of phorbol ester-stimulated GAP-43 phosphorylation was seen between IGCs prepared from whole forebrains and those derived from septal and hippocampal areas. Second, our experiments with intact IGCs show that 2.5s NGF stimulates phosphorylation of GAP-43 within 1 min with a Kd of 2 x lO-'O M that is significantly higher than the Kd for binding to its low-affinity receptor, which is 1 O-9 M. Finally, although NGF can bind with both high and low affinity to the same gene product its biological effects are mediated solely following highaffinity interactions (Hosang and Shooter, 1985, 1987; . The high-affinity receptor seems to be formed from the coupling of the NGF-binding protein to an intracellular component capable of transducing the extracellular binding event; such transduction is not evident following binding of NGF to the low-affinity receptor (see, e.g., Hempstead et al., 1990, 199 1; Meakin and Shooter, 1991) . Our data, which shows the intracellular activation of a kinase following treatment of intact IGCs with concentrations of NGF sufficient to activate a high-affinity receptor, therefore suggest that GAP-43 phosphorylation may be part of the repertoire of biologically relevant responses of growth cones to NGF. It is possible that other target-derived growth factors may have similar effects on GAP-43 phosphorylation; a number of molecules with sequence homology to NGF have been isolated, for example BDNF and NT3, and there may be cross reactivity between these molecules and their receptors (Leibrock et al., 1989; Hohn et al., 1990; Maisonpierre et al., 1990a,b) .
Knowledge of how the NGF-binding event is transduced intracellularly is incomplete. Unlike other growth factor receptors, the NGF-binding protein does not have intrinsic kinase activity (Grob et al., 1985; Taniuchi et al., 1986) . Nevertheless, it is able to activate a number of second messengers and protein kinases (McTigue et al., 1985; Hama et al., 1986; Rowland et al., 1987; Hall et al., 1988; Maher, 1988 , Hempstead et al., 1991 . While our results show NGF-dependent phosphorylation of GAP-43 to be occurring on serine41, the only site phosphorylated by kinase C in vitro, they nevertheless do not rule out the possibility that in vivo this residue may also be a substrate for other serine kinases.
The monoclonal antibody 2Gl2 also allowed us to detect calcium-stimulated dephosphorylation of GAP-43. This dephosphorylation was detected under two circumstances. In the presence of extracellular calcium and A23187, dephosphorylation occurred and could only be prevented by EGTA. In the absence of added calcium, dephosphorylation of GAP-43 would occur following NGF-stimulated phosphorylation whenever NGF was removed from the incubation buffer but could be prevented by keeping NGF present throughout. Taken together with our previous results showing the precise temporal regulation of GAP-43 phosphorylation in vivo (Meiri et al., 1991) , these results imply that maintenance of the phosphorylated state subsequent to its induction requires continued extracellular input, in this case by NGF. We have not identified the calciumdependent phosphatase responsible for dephosphorylating GAP-43, but the results that show that it is not inhibitable by 1 I.LM okadaic acid suggest that it is not phosphatase 2A (Haystead et al., 1989) . Consistent with these results, calcium-and calmodulin-dependent dephosphorylation of GAP-43 in vitro by calcineurin has been reported (Liu and Storm, 1989) .
Is there normally a balance between phosphorylation and dephosphorylation of GAP-43 in growth cones, and if so how might it be regulated? These results do not allow us to identify the source of calcium but suggest that it is locally regulated so that we might expect to see changes in levels of phosphorylated GAP-43 that reflect some underlying changes in growth cone behavior. In support ofthis speculation, we have recent evidence that in regenerating growth cones in vitro, different growth cones arising from the same cell body, and also different areas of the Grob PM, Ross AH, Koprowski M, Bothwell MA (1985) Characterization of the human melanoma nerve growth factor receptor. J Biol respect to GAP-43 (Dent and Meiri, 1991) . physiologically relevant signals, we believe that our data further support the hypothesis that kinase activation and phosphorylation of GAP-43 on serine41 provide a means whereby the growth cone can respond similarly to stimuli of diverse origins.
In molecular terms, it will now be necessary to determine whether NGF-maintained phosphorylation of GAP-43 affects its spe- 
